Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Other Operating Expenses (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Other Operating Expenses data on record, last reported at -$2.0 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 300.0% year-over-year to -$2.0 million; the TTM value through Dec 2025 reached -$3.0 million, up 98.46%, while the annual FY2025 figure was -$3.0 million, 98.46% up from the prior year.
  • Other Operating Expenses reached -$2.0 million in Q4 2025 per INDV's latest filing, down from -$1.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.0 million in Q4 2024 and bottomed at -$160.0 million in Q2 2024.